Obagi-C Rx Night Cream Recall: Missing Instructions Risk Misuse
Obagi-C Rx System C-Therapy Night Cream (2 oz) is recalled due to missing product instructions. Consumers should check labels for NDC 62032-222-02 and lot 2578400. This affects prescription-only products sold in the US.
Lower-risk recall
Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.
Contact the company
What happened, in plain English
Obagi-C Rx System C-Therapy Night Cream (2 oz) bottles are being recalled because they lack the product insert and outer carton with safety instructions. This means users might not know how to use the product safely, potentially leading to improper application or skin reactions. Read more at govinfonow.com/recall/41521-obagi-c-rx-night-cream-recall-missing-instructions-risk-misuse.
Source Summary by GovInfoNow · govinfonow.com/recall/41521-obagi-c-rx-night-cream-recall-missing-instructions-risk-misuse · Updated October 8, 2026 · FDA enforcement record: FDA #D-0998-2017
Cite this page
“Obagi-C Rx Night Cream Recall: Missing Instructions Risk Misuse.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41521-obagi-c-rx-night-cream-recall-missing-instructions-risk-misuse. Based on FDA recall #D-0998-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0998-2017%22&limit=1).
Why it’s dangerous
The product lacks the required instructions and packaging, so users may not know how to apply it correctly. This could lead to skin irritation or other reactions if the product is used improperly.
Who’s affected
Prescription-only users who purchased the Obagi-C Rx System C-Therapy Night Cream (2 oz) bottle with NDC 62032-222-02 and lot number 2578400. People with sensitive skin may be at slightly higher risk due to potential misuse.
How to tell if you have this one
Check for the product label with NDC 62032-222-02 and lot number 2578400. The bottle is a 2 oz (57g) prescription-only cream sold by OMP, Inc. in the US.
- Brand
Obagi- Category
Drug
What to do — step by step
Check Product Label
Look for the NDC code 62032-222-02 and lot number 2578400 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0998-2017 (June 28, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0998-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.